Michael Hill

• Optimum dose of vitamin D for disease prevention in older people: BEST-D trial of vitamin D in primary care.

  Hin H. et al, (2016), Osteoporos Int

• Perioperative Rosuvastatin in Cardiac Surgery.

  Zheng Z. et al, (2016), The New England journal of medicine, 374, 1744 - 1753

• Lipoprotein-Associated Phospholipase A2 Loss-of-Function Variant and Risk of Vascular Diseases in 90,000 Chinese Adults.

  Millwood IY. et al, (2016), J Am Coll Cardiol, 67, 230 - 231

• Role of a functional polymorphism in the F2R gene promoter in sarcoidosis.

  Platé M. et al, (2015), Respirology, 20, 1285 - 1287

• Estimation of the optimum dose of vitamin D for disease prevention in older people: rationale, design and baseline characteristics of the BEST-D trial.

  Clarke R. et al, (2015), Maturitas, 80, 426 - 431

• Use of gel-based separator tubes to stabilise phosphate in mailed blood samples.

  Herrington W. et al, (2015), Clin Chim Acta, 439, 112 - 114

• Estimation of the optimum dose of vitamin D for disease prevention in older people: Rationale, design and baseline characteristics of the BEST-D trial

  Clarke R. et al, (2015), Maturitas, 80, 426 - 431

• Impact of a functional polymorphism in the PAR-1 gene promoter in COPD and COPD exacerbations.

  Platé M. et al, (2014), Am J Physiol Lung Cell Mol Physiol, 307, L311 - L316

• Vitamin D and risk of death from vascular and non-vascular causes in the Whitehall study and meta-analyses of 12,000 deaths.

  Tomson J. et al, (2013), Eur Heart J, 34, 1365 - 1374

• Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection Study.

  Parish S. et al, (2012), Circulation, 125, 2469 - 2478

• The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.

  Baigent C. et al, (2011), Lancet, 377, 2181 - 2192

• Variation in iron homeostasis genes between patients with ARDS and healthy control subjects.

  Lagan AL. et al, (2008), Chest, 133, 1302 - 1311

• Escape from the matrix: multiple mechanisms for fibroblast activation in pulmonary fibrosis.

  Laurent GJ. et al, (2008), Proc Am Thorac Soc, 5, 311 - 315

• Regulation of matrix turnover: fibroblasts, forces, factors and fibrosis.

  Laurent GJ. et al, (2007), Biochem Soc Trans, 35, 647 - 651

• Functional prostaglandin-endoperoxide synthase 2 polymorphism predicts poor outcome in sarcoidosis.

  Hill MR. et al, (2006), Am J Respir Crit Care Med, 174, 915 - 922

• Promoter variants in tissue inhibitor of metalloproteinase-3 (TIMP-3) protect against susceptibility in pigeon breeders' disease.

  Hill MR. et al, (2004), Thorax, 59, 586 - 590

• LD mapping of maternally and non-maternally derived alleles and atopy in FcepsilonRI-beta.

  Traherne JA. et al, (2003), Hum Mol Genet, 12, 2577 - 2585

• Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response.

  Papafili A. et al, (2002), Arterioscler Thromb Vasc Biol, 22, 1631 - 1636

• Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome.

  Marshall RP. et al, (2002), Am J Respir Crit Care Med, 166, 646 - 650

• Genetic polymorphisms associated with susceptibility and outcome in ARDS.

  Marshall RP. et al, (2002), Chest, 121, 68S - 69S

• Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2.

  Akers IA. et al, (2000), Am J Physiol Lung Cell Mol Physiol, 278, L193 - L201

• Quantification of house-dust-mite populations

  Hill MR., (1998), Allergy: European Journal of Allergy and Clinical Immunology, Supplement, 53, 18 - 23

• Quantification of house-dust-mite populations.

  Hill MR., (1998), Allergy, 53, 18 - 23

• A genome-wide search for quantitative trait loci underlying asthma.

  Daniels SE. et al, (1996), Nature, 383, 247 - 250

• A new variant of the beta subunit of the high-affinity receptor for immunoglobulin E (Fc epsilon RI-beta E237G): associations with measures of atopy and bronchial hyper-responsiveness.

  Hill MR. and Cookson WO., (1996), Hum Mol Genet, 5, 959 - 962

• Fc epsilon RI-beta polymorphism and risk of atopy in a general population sample.

  Hill MR. et al, (1995), BMJ, 311, 776 - 779

• ATOPY IN AUSTRALIA - REPLY

  HILL M. and COOKSON W., (1995), NATURE GENETICS, 10, 260 - 260

• Detection of a recessive major gene for high IgE levels acting independently of specific response to allergens.

  Dizier MH. et al, (1995), Genet Epidemiol, 12, 93 - 105

• Genetic linkage of T-cell receptor alpha/delta complex to specific IgE responses.

  Moffatt MF. et al, (1994), Lancet, 343, 1597 - 1600

• Comparative IgE responses to extracts of five species of house dust mite, using western blotting.

  Hill MR. et al, (1993), Clin Exp Allergy, 23, 110 - 116

• Molecular characterisation of group I allergen Eur m I from house dust mite Euroglyphus maynei.

  Kent NA. et al, (1992), Int Arch Allergy Immunol, 99, 150 - 152

• Effect of Processing Delay and Storage Conditions on Urine Albumin-to-Creatinine Ratio

  Herrington W. et al, Clinical Journal of the American Society of Nephrology

• Diabetes and Cause-Specific Mortality in Mexico City

  Herrington W. et al, New England Journal of Medicine

• A phenome-wide association study of a lipoproteinassociated phospholipase A2 loss-of-function variant in 90 000 Chinese adults

  Millwood IY., International Journal of Epidemiology

Recent Publications

• Optimum dose of vitamin D for disease prevention in older people: BEST-D trial of vitamin D in primary care.

  Hin H. et al, (2016), Osteoporos Int

• Perioperative Rosuvastatin in Cardiac Surgery.

  Zheng Z. et al, (2016), The New England journal of medicine, 374, 1744 - 1753

• Lipoprotein-Associated Phospholipase A2 Loss-of-Function Variant and Risk of Vascular Diseases in 90,000 Chinese Adults.

  Millwood IY. et al, (2016), J Am Coll Cardiol, 67, 230 - 231

• Role of a functional polymorphism in the F2R gene promoter in sarcoidosis.

  Platé M. et al, (2015), Respirology, 20, 1285 - 1287

• Estimation of the optimum dose of vitamin D for disease prevention in older people: rationale, design and baseline characteristics of the BEST-D trial.

  Clarke R. et al, (2015), Maturitas, 80, 426 - 431